Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Four-arm randomized open-label tacrolimus regimens in kidney transplant recipients
2007-005376-13Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Feb 2008
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tacrolimus in kidney allograft rejection (4 arms), sponsored by Astellas Pharma. Primary endpoint: Primary non-inferiority endpoint. Started Feb 2008; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on 2007-005376-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005376-13.